what was explained to me was FDA can grant accelerated approval for CHF treatment based on its overwhelming benefits of reducing mortality and its reduction of inflammation marker around the aorta tissue. CHF and LB treatments look very positive, So goes GVHD however a jump through hoop trial will be required, however I'm optimistic we will prevail.
what was explained to me was FDA can grant accelerated approval...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
0.025(2.73%) |
Mkt cap ! $1.078B | |||
| Open | High | Low | Value | Volume |
| 92.5¢ | 95.0¢ | 89.0¢ | $5.881M | 6.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 97401 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.0¢ | 35405 | 8 |
View Market Depth
| Last trade - 14.11pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
93.5¢ |
Change
0.025 ( 3.09 %) |
||||
| Open | High | Low | Volume | ||
| 92.0¢ | 95.0¢ | 89.5¢ | 1521971 | ||
| Last updated 14.34pm 26/04/2024 ? | |||||
| MSB (ASX) Chart |